drugset / Trial / NCT00128934

Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder

NCT00128934

Phase 3 Completed 744 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to determine whether levonorgestrel (LNG)/ethinyl estradiol (EE) is effective in treating the symptoms of severe premenstrual syndrome (PMS).

Timeline

Start
2005-08
Primary completion
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Levonorgestrel Small molecule 90 ug Oral
Subject ethinyl estradiol Small molecule 20 ug Oral

Indications